Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission

We retrospectively analyzed the outcomes of all acute myelogenous leukemia (AML) patients in first remission (n = 44; median age = 48 years; high-risk cytogenetics = 59%) who received unrelated donor hematopoietic cell transplantation (HCT) with myeloablative conditioning regimen of i.v. busulfan, f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bashir, Qaiser, Andersson, Borje S., Fernandez-Vina, Marcelo, de Padua Silva, Leandro, Giralt, Sergio, Chiattone, Alexandre, Wei, Wei, Sharma, Manish, Anderlini, Paolo, Shpall, Elizabeth J., Popat, Uday, Rodrigues, Morgani, Champlin, Richard E., de Lima, Marcos
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080632/
https://ncbi.nlm.nih.gov/pubmed/21087679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.11.012
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares